TSU-TSAIR CHI, Ph.D., born in China, came to the US and earned his Ph.D. in Biochemistry from the Waksman Institute of Microbiology at Rutgers State University, New Jersey in 1978. Since then, he has been involved in Infectious Disease work at E.R. Squibb and Sons, Inc. in New Jersey and Cancer Screening at Warner-Lambert/Parke-Davis Co. in Michigan. He was also the Laboratory Director at Omicron Incorporated in Redlands, California where he worked in the fields of cancer and atherosclerosis. In 1988, Dr. Chi developed a California state-licensed Neostop Anti-Tumor Vaccine for poultry. He has also received a patent for the detection of antibodies against a chronic gonadotropin-like substance.
Dr. Chi has published articles on his herbal formulas in Journals such as the “International Journal of Integrative Oncology” and “Townsend Letter for Doctors and Patients.” Some of his herbal formulas include Myomin, an aromatase reducer for estrogen-dominant conditions and Angiostop, a supplement that blocks new blood vessel formation from tumors. Additional clinical cancer research on his supplements are published in the “International Journal of Cancer” and “Cancer Biology & Therapy.”
For 26 years Dr. Chi has been the President of Chi’s Enterprise, Inc. located in Anaheim, California and he may be reached by phone 714-777-1542, fax 714-777-7186, e-mail
firstname.lastname@example.org and website www.chi-health.com.
He will speak on The Role Of Herbal Formulas In Cancer Management.